CGVYX
Price
$31.10
Change
+$0.17 (+0.55%)
Updated
Jul 31 closing price
Net Assets
21.64B
RWIBX
Price
$79.46
Change
+$0.70 (+0.89%)
Updated
Jul 31 closing price
Net Assets
157.74B
Interact to see
Advertisement

CGVYX vs RWIBX

CGVYX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
CGVYX vs. RWIBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGVYX is a Buy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 158B vs. CGVYX (21.6B). CGVYX pays higher dividends than RWIBX: CGVYX (0.79) vs RWIBX (0.71). CGVYX was incepted earlier than RWIBX: CGVYX (7 years) vs RWIBX (24 years). RWIBX (1.51) is less costly to investors than CGVYX (0.80). RWIBX is a more actively managed with annual turnover of: 44.00 vs. CGVYX (35.00). CGVYX (250) and RWIBX (250) have matching initial minimum investment requirements. CGVYX annual gain was more profitable for investors over the last year : 18.92 vs. RWIBX (14.60). CGVYX return over 5 years is better than : 52.77 vs. RWIBX (28.91).
CGVYXRWIBXCGVYX / RWIBX
Total Expense Ratio0.801.5153%
Annual Report Gross Expense Ratio0.801.5153%
Fund Existence7 years24 years-
Gain YTD10.01113.50374%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets21.6B158B14%
Annual Yield % from dividends0.790.71111%
Returns for 1 year18.9214.60130%
Returns for 3 years54.1840.64133%
Returns for 5 years52.7728.91183%
Returns for 10 yearsN/A86.81-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX51.730.36
+0.70%
PGIM Quant Solutions Large-Cap Index A
EMAAX18.21-0.01
-0.05%
Gabelli Entpr Mergers & Acquisitions A
MCPRX23.18-0.02
-0.09%
MFS Mid Cap Growth R2
MSMJX32.27-0.09
-0.28%
Invesco Main Street Mid Cap R5
BRSDX16.73-0.09
-0.54%
MFS Blended Research Small Cap Eq A